Improved blood-brain-barrier permeability and tissue distribution following the oral administration of a food-grade formulation of curcumin with fenugreek fibre

Journal of Functional Foods

Volumn 14, Issue , 2015, Pages 215-225

  Krishnakumar, I M ^a   Maliakel, Abhilash ^a   Gopakumar, G ^a   Kumar, Dinesh ^a   Maliakel, Balu ^a   Kuttan, Ramadasan ^b  

^a R and D Laboratory   (India)

^b AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Blood brain barrier; Curcumin; Functional food; Oral bioavailability; Pharmacokinetics; Tissue distribution

Indexed keywords

RATTUS NORVEGICUS; TRIGONELLA FOENUM-GRAECUM;

EID: 84926367015     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.01.049     Document Type: Article

References (36)

1. Begum A.N., Jones M.R., Lim G.P., Morihara T., Kim P., Heath D.D., Rock C.L., Pruitt M.A., Yang F., Hudspeth B., Hu S., Faull K.F., Teter B., Cole G.M., Frautschy S.A. Curcumin structure-function, bioavailability, and efficacy in models of nueroinflammation and Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics 2008, 326:196-208.
2. Chiu S.S., Lui E., Majeed M., Vishwanatha J.K., Ranjan A.P., Maitra A., Pramanik D., Smith J.A., Helson L. Differential distribution of intravenous curcumin formulations in rat brain. Anticancer Research 2011, 31:907-912.
3. Cuomo J., Appendino G., Dern A.S., Schneider E., McKinnon T.P., Brown M.J., Togni S., Dixon B.M. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products 2011, 74:664-669.
4. Garcea G., Jones D.J., Singh R., Dennison A.R., Farmer P.B., Sharma R.A., Steward W.P., Gescher A.J., Berry D.P. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. British Journal of Cancer 2004, 90:1011-1015.
5. Gupta S.C., Patchva S., Aggarwal B.B. Therapeutic roles of curcumin: Lessons learned from clinical trials. The AAPS Journal 2013, 15:195-218.
6. Hamaguchi T., Ono K., Yamada M. Curcumin and Alzheimer's disease. CNS Neuroscience & Therapeutics 2010, 16:285-297.
7. Hasima N., Aggarwal B.B. Cancer-linked targets modulated by curcumin. International Journal of Biochemistry and Molecular Biology 2012, 3:328-351.
8. Ireson C., Orr S., Jones D.J., Verschoyle R., Lim C.K., Luo J.L., Howells L., Plummer S., Jukes R., Williams M., Steward W.P., Gescher A. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Research 2001, 61:1058-1064.
9. Jadhav B.K., Mahadik K.R., Paradkar A.R. Development and validation of improved reversed phase-HPLC method for simultaneous determination of curcumin, demethoxycurcumin and bis-demethoxycurcumin. Chromatographia 2007, 65:483-488.
10. Jantarat C. Bioavailability enhancements techniques of herbal medicine: A case example of curcumin. International Journal of Pharmacy and Pharmaceutical Sciences 2013, 5:493-500.
11. Jäger R., Lowery R.P., Calvanese A.V., Joy J.M., Purpura M., Wilson J.M. Comparative absorption of curcumin formulations. Nutrition Journal 2014, 13:11.
12. Kim S.J., Son T.G., Park H.R., Park M., Kim M.S., Kim H.S., Chung H.Y., Mattson M.P., Lee J. Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. Journal of Biological Chemistry 2008, 283:14497-14505.
13. Krishnakumar I.M., Kumar D., Ravi A., Kuttan R., Maliakel B. Enhanced bioavailability of a novel formulation of curcumin using fenugreek soluble dietary fibre. Journal of Functional Foods 2012, 4:348-354.
14. Krishnakumar I.M., Maliakel B. Fenugreek dietary fibre: A novel class of functional food ingredient. Agro Food Industry Hi-Tech 2008, 19:18-21.
15. Lao C.D., Ruffin M.T., Normolle D., Heath D.D., Murray S.I., Bailey J.M., Boggs M.E., Crowell J., Rock C.L., Brenner D.E. Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine 2006, 6-10.
16. Liju V.B., Jeena K., Kumar D., Kuttan R., Maliakel B., KrishnaKumar I.M. Enhanced bioavailability and safety of curcumagalactomannosides as dietary ingredient. Food & Function 2014, In press. 10.1039/C4FO00749B.
17. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience 2001, 21:8370-8377.
18. Mancuso C., Siciliano R., Barone E. Curcumin and Alzheimer disease: This marriage is not to be performed. Journal of Biological Chemistry 2011, 286:le3.
19. Marczylo T.H., Steward W.P., Gescher A.J. Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography method. Journal of Agricultural and Food Chemistry 2009, 57:797-803.
20. Moghimi S.M., Hunter A.C., Murray J.C. Long circulating and target specific nanoparticles: Theory to practice. Pharmacological Reviews 2001, 53:283-318.
21. Nishikawa H., Tsutsumi J., Kitani S. Anti-inflammatory and anti-oxidative effect of curcumin in connective tissue type mast cell. Journal of Functional Foods 2013, 5(2):763-772.
22. Okada K., Wangpoengtrakul C., Tanaka T., Toyokuni S., Uchida K., Osawa T. Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. Journal of Nutrition 2001, 131:2090-2095.
23. Pal A., Sung B., Bhanu Prasad B.A., Schuber P.T., Prasad S., Aggarwal B.B., Bornmann W.G. Curcuminglucuronides: Assessing the proliferative activity against human cell lines. Bioorganic & Medicinal Chemistry 2014, 22:435-439.
24. Pan M.H., Lin-Shiau S.Y., Lin J.K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochemical Pharmacology 2000, 60:1665-1676.
25. Panahi Y., Saadat A., Beiraghdar F., Hosseini Nouzari S.M., Jalalian H.R., Sahebkar A. Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial. Journal of Functional Foods 2014, 6:615-622.
26. Prasad S., Tyagi A.K., Aggarwal B.B. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Research and Treatment 2014, 46:2-18.
27. Ravichandran R. Pharmacokinetic study of nanoparticulate curcumin: Oral formulation for enhanced bioavailability. Journal of Biomaterials and Nanobiotechnology 2013, 4:291-299.
28. Ray B., Bisht S., Maitra A., Maitra A., Lahin D.K. Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc) in the neuronal cell cultural and animal model: Implications for Alzheimer's disease. Journal of Alzheimer's Disease 2011, 23:61-77.
29. Ringman J.M., Frautschy S.A., Teng E., Begum A.N., Bardens J., Beigi M., Gylys K.H., Badmaev V., Heath D.D., Apostolova L.G., Porter V., Vanek Z., Marshall G.A., Hellemann G., Sugar C., Masterman D.L., Montine T.J., Cummings J.L., Cole G.M. Oral curcumin for Alzheimer's disease: Tolerability and efficacy in a 24-weeek randomized double blind placebo-controlled study. Alzheimer's Research & Therapy 2012, 43:43.
30. Sandur S.K., Pandey M.K., Sung B., Ahn K.S., Murakami A., Sethi G., Limtrakul P., Badmaev V., Aggarwal B.B. Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate antiinflammatory and antiproliferative responses through a ROS independent mechanism. Carcinogenesis 2007, 28:1765-1773.
31. Sasaki H., Sunagawa Y., Takahashi K., Imaizumi A., Fukuda H., Hashimoto T., Wada H., Katanasaka Y., Kakeya H., Fujita M., Hasegawa K., Morimoto T. Innovative preparation of curcumin for improved oral bioavailability. Biological & Pharmaceutical Bulletin 2011, 34:660-665.
32. Schiborr C., Kocher A., Behnam D., Jandasek J., Toelstede S., Frank J. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Molecular Nutrition & Food Research 2014, 58:516-527.
33. Schmidt S., Gonzalez D., Derendrof H. Significance of protein binding in pharmacokinetics and pharmacodynamics. Journal of Pharmaceutical Sciences 2010, 99:1107-1122.
34. Stolnik S., Illum L., Davis S.S. Long circulating micro particulate drug carriers. Advanced Drug Delivery Reviews 1995, 16:195-214.
35. Tsai Y.M., Chien C.F., Lin L.C., Tsai T.H. Curcumin and its nano formulation: The kinetics of tissue distribution and blood-brain-barrier penetration. International Journal of Pharmaceutics 2011, 06:030. 10.1016/j.ijpharm.06-030.
36. Yallapu M.M., Jaggi M., Chauhan S.C. Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discovery Today 2012, 17:71-80.